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Abstract 
 
The aim of the study was to investigate cardiovascular effects of two adenosine constant rate 
infusion (CRI) doses in dogs.  
Ten healthy beagle dogs were included into the experimental study. After sedation with 
butorphanol, anaesthesia was induced with propofol and maintained with sevoflurane. Each 
dog received 2 consecutive adenosine CRI’s: 140 µg kg-1minute-1 (A140) followed by 280 µg 
kg-1minute-1 (A280). Pulse rate, invasive arterial blood pressures and stroke volume 
[measured by magnetic resonance phase contrast angiography] were measured at baseline, 3 
minutes after starting and 3 and 10 minutes after discontinuing adenosine. Cardiac output, 
cardiac index and approximated systemic vascular resistance (approxSVR) were calculated. 
Arterial blood gases, co-oximetry, electrolytes, glucose and lactate were measured and 
oxygen content and delivery calculated. Data were analysed using one-way repeated measures 
ANOVA (p < 0.05).  
A140 and A280 resulted in a significant decrease in arterial blood pressures and approxSVR. 
No significant changes were detected for the other variables. All values returned to baseline 
within 3 minutes after adenosine discontinuation. 
Adenosine decreases arterial blood pressures by vasodilatation in healthy dogs. The observed 
effects were not dose-dependent.  
 
 
Adenosine, anaesthesia, cardiovascular, cMRI, dog 
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Zusammenfassung 
 
Das Ziel der Studie war es, die kardiovaskulären Effekte von zwei Adenosin 
Dauertropfinfusionen (DTI) zu untersuchen. 
Zehn gesunde Beagle Hunde wurden in die experimentelle Studie einbezogen. Nach einer 
Sedation mit Butorphanol wurde die Anästhesie mit Propofol eingeleitet und mit Sevofluran 
aufrechterhalten. Jeder Hund bekam eine tiefere Dosis von 140 µg kg-1minute-1, gefolgt von 
der höheren mit 280 µg kg-1minute-1 Adenosin. Kardiovaskuläre Parameter wie Pulsfrequenz, 
invasive arterielle Blutdrucke und Schlagvolumen (Messung mittels MRT Phasenkontrast 
Angiographie) wurden vor Start der DTI, 3 Minuten nach Start und 3 und 10 Minuten nach 
Stopp der jeweiligen DTI gemessen. Herzminutenvolumen, Herzminutenvolumenindex und 
angenäherter peripherer Gefässwiderstand (approxSVR) wurden berechnet. Arterielle 
Blutgase, Cooximetrie, Elektrolyte, Glucose und Lactat wurden gemessen und der 
Sauerstoffgehalt des Blutes sowie der Sauerstoffverbrauch berechnet. Die Daten wurden 
mittels einfaktorieller-ANOVA mit Messwiederholung ausgewertet (p < 0.05). 
Beide Dosen führten zu einem Abfall der arteriellen Blutdrucke sowie des approxSVR. Für 
die restlichen Variablen wurden keine signifikanten Änderungen festgestellt. Alle Messungen 
kehrten 3 Minuten nach Stopp von Adenosin auf die Ausgangswerte zurück.  
Adenosin reduziert den arteriellen Blutdruck bei gesunden Hunden mittels Vasodilatation. 
Der beobachtete Effekt war nicht Dosis abhängig.  
 
Adenosin, Anästhesie, kardiovaskulär, cMRI, Hund 
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Abstract
Objective Adenosine induces vasodilatation. The
aim of this study was to investigate cardiovascular
effects of two adenosine constant rate infusion
(CRI) doses in dogs.
Study design Experimental, longitudinal repeated
measure design.
Animals Ten healthy purpose-bred Beagle dogs.
Methods Each dog was sedated with butorpha-
nol. Anaesthesia was induced with propofol
intravenously and maintained with sevoﬂurane
(inspired oxygen fraction ¼ 47e55%).
Controlled mechanical ventilation was used to
maintain normocapnia. Two doses of adenosine
were administered as CRIs to each dog: 140 mg
kge1 minutee1 (A140) followed by 280 mg kge1
minutee1 (A280). Pulse rate, invasive arterial
pressure and stroke volume (by magnetic reso-
nance phase contrast angiography) were
measured at baseline, 3 minutes after starting
adenosine and 3 and 10 minutes after dis-
continuing adenosine. Cardiac output, cardiac
index and approximated systemic vascular re-
sistances (approximate SVR) were calculated.
Additionally, arterial blood gases, co-oximetry,
electrolytes, glucose and lactate were
measured and oxygen content and delivery
calculated. One-way repeated measures analysis
of variance (p < 0.05) was used for data
analysis.
Results A140 and A280 resulted in a signiﬁcant
decrease in arterial blood pressure [systolic (p ¼
0.008), mean (p ¼ 0.003), and diastolic arterial
pressure (p ¼ 0.004)] and approximate SVR (p ¼
0.008) compared with baseline. No signiﬁcant
changes were detected for the other variables. All
values returned to baseline within 3 minutes after
adenosine discontinuation.
Conclusions and clinical relevance Adenosine CRI
decreases arterial pressure by vasodilatation in
healthy dogs. No additional effects were observed
with the higher dose. The effects in compromised
dogs remain to be investigated.
Keywords adenosine, anaesthesia, cardiovascu-
lar, cMRI, dog.
Introduction
Adenosine is an extracellular purine nucleoside sig-
nalling molecule that is present in every cell of the
body. Its half-life is seconds to minutes (Moser et al.
1989) and its biological effects are mediated via
four receptor subtypes (A1, A2A, A2B, A3). Adenosine
receptors seem to play a dynamic role not only in
normal cell physiology but also as modulators in
disease processes (Sheth et al. 2014).
In humans, adenosine depresses atrioventricular
conduction and induces coronary vasodilatation
(Faulds et al. 1991). Therefore, and based on its short
duration of action, adenosine is commonly used for
diagnosis of coronary heart disease, and for diagnosis
Veterinary Anaesthesia and Analgesia 2019, 46, 289e298 https://doi.org/10.1016/j.vaa.2018.12.007
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and emergency treatment of complex tachycardias
(DiMarco et al. 1983; Rankin et al. 1989; Verani
et al. 1990; Jenni et al. 2009; Greenwood et al.
2012; Bailey et al. 2016). Furthermore, adenosine
has been extensively investigated for its anti-
nociceptive and anti-inﬂammatory properties and its
importance during ischemia and shock (Sjolund et al.
2001; Skrabanja et al. 2005; Hayashida et al. 2006;
Granfeldt et al. 2014). Due to its wide ﬁeld of appli-
cability, adenosine is expected to gain importance in
veterinary medicine. Therefore, more controlled tri-
als, especially investigating cardiovascular effects, in
companion animals are necessary.
The cardiovascular effects of adenosine, in partic-
ular hypotension, have been studied in humans and
dogs (Lagerkranser et al. 1984; Sollevi et al. 1984;
Asakawa et al. 2007). However, to the authors’
knowledge, cardiovascular effects have not been
investigated in anaesthetized dogs using modern
anaesthetic agents.
The aims of this study were: 1) To investigate the
effects of adenosine on the cardiovascular system of
healthy anaesthetized dogs; and 2) to compare two
different adenosine doses administered as continuous
rate infusions (CRI).
We hypothesized that adenosine CRI will result in a
dose-dependent hypotension induced primarily by
vasodilatation rather than by decreasing cardiac
output.
Methods
All examinations were performed with written
permission of the Committee for Animal Experimen-
tation of the Canton Zürich, Switzerland (License
number ZH001-15) and were performed in
consensus with the ARRIVE guidelines.
Animals
Ten healthy, adult purpose-bred Beagle dogs were
recruited for this study. They were included if deemed
healthy based on clinical and routine blood exami-
nation (haematocrit and standard biochemical blood
analysis).
Exclusion criteria included suspicion of cardio-
vascular disease and cardiovascular instability
[mean arterial blood pressure (MAP) < 60 mmHg
and pulse rate (PR) > 130 beats minutese1] during
anaesthesia prior to starting baseline measure-
ments. The dogs were housed in groups of two and
fasted for 11 hours before the experiment but had
free access to water.
Preanaesthetic preparation and anaesthesia
Dogs were premedicated with butorphanol (0.2 mg
kge1; Alvegesic 1% forte; Virbac AG, Switzerland)
intramuscularly. After 10 minutes, catheters (Vaso-
Vet 22 gauge; Eickemeyer, Switzerland) were inser-
ted into both the cephalic veins. One catheter was
used exclusively for adenosine infusion. After 3 mi-
nutes of preoxygenation, anaesthesia was induced
with propofol 4e6 mg kge1 intravenously (IV)
(Propofol 1% MCT Fresenius; Fresenius Kabi AG,
Switzerland). Dogs were orotracheally intubated with
a cuffed endotracheal tube, and the tube was con-
nected to an anaesthetic machine via a circle system
(Aestivia S5, 7900; SmartVent, Switzerland).
Anaesthesia was maintained with sevoﬂurane (Sev-
orane; abbVie AG, Switzerland) in an oxygen-air
mixture (O2-air: 1:1; inspired oxygen fraction ¼
47e55%]. Volume-controlled mechanical ventila-
tion with a tidal volume (VT) of 10e15 mL kg
e1 and
respiratory rate (fR) of 12e25 breaths minute
e1
ensured normocapnia [end-tidal carbon dioxide
(PE0CO2) between 36 and 38 mmHg (4.8e5.1 kPa)].
A 22 gauge arterial catheter (BD Insyte-A; Becton,
Dickinson and Company, China) was advanced into a
metatarsal artery for continuous blood pressure
measurements and arterial blood sampling. A new
pressure transducer for each dog (DPT-6000 system;
Codan Medical AG, Switzerland) was zeroed to at-
mospheric pressure and levelled to the height of the
shoulder joint. Monitoring was performed with a
multiparameter monitor (Datex-Ohmeda N-MRI2-
01; GE Healthcare, Finland) and consisted of pulse
oximetry, invasive arterial pressure, inspired and
expired gases including end-tidal sevoﬂurane con-
centration in % (FE0Sevo), spirometry and
capnography.
All dogs received Ringer’s lactate solution at 5 mL
kge1 houre1 (Ringer-Lactate; Fresenius Kabi AG) IV.
If mean arterial blood pressure dropped below 60
mmHg and/or PR raised above 130 beats minutee1,
boluses of Ringer’s lactate (3 mL kge1 over 10 mi-
nutes up to a maximum of 20 mL kge1 total dose), if
necessary, followed by balanced hydroxyethyl starch
130/0.4 (Voluven 6% balanced; Fresenius Kabi AG)
(3 mL kge1 over 10 minutes up to 10 mL kge1 total
dose) were administered IV until reaching MAP > 60
mmHg and PR < 130 beats minutee1.
Study design
Baseline measurements were taken once basic
magnetic resonance imaging (MRI) studies were
Two adenosine constant rate infusions in anaesthetized dogs FB Joerger et al.
© 2019 Published by Elsevier Ltd on behalf of Association of Veterinary Anaesthetists and American College of Veterinary
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completed and anaesthesia was considered stable.
Measurements always followed the same order: 1)
recording of variables from the multiparameter
monitor [PR, MAP, systolic (SAP) and diastolic
arterial pressure (DAP), expired and inspired gases,
fR]; 2) cardiac MRI scans; and 3) arterial blood
sampling.
After recording baseline measurements, adenosine
was started as a CRI. Adenosine (Krenosin 6 mg/2
mL; Sanoﬁ-aventis, Switzerland) was administered
through the right cephalic catheter using a calibrated
syringe driver (Syramed mSP6000; Arcomed,
Switzerland). All dogs were ﬁrst administered a lower
infusion dose of adenosine (A140: 140 mg kge1
minutee1), followed by a higher dose (A280: 280 mg
kge1 minutee1).
There was a minimum 3 minute stabilization
period before taking measurements after starting
A140, and only if no further changes in MAP were
observed. As soon as all measurements were recor-
ded, the adenosine dose was increased and mea-
surements for A280 were taken after an additional 3
minute stabilization period. After the adenosine CRI
was discontinued, measurements were repeated after
3 and 10 minutes (Fig. 1).
Cardiac magnetic resonance imaging
For the cardiac MRI (cMRI) scans, the dogs were
placed in dorsal recumbency with the head towards
the gantry. A board-certiﬁed radiologist (MD) per-
formed cMRI with a 3 Tesla system (Philips Ingenia
3T with a dStream body coil Solution; Philips AG,
Switzerland). Vector cardiography with four MR-safe
electrodes (750 Clear Tape Electrodes; Kendall
Anandic Medical System SA; Switzerland) attached to
both sides of the chest wall over the heart and a pe-
ripheral pulse unit (Philips AG, Switzerland) placed
on the tongue monitored cardiac action.
Initial scout views were performed to determine
cardiac location. Cine gradient echo sequences of the
cardiac anatomy allowed planning of the ﬂow sensi-
tive sequences perpendicular to the ﬂow direction.
Parameters used were time to echo (2 ms), time to
repetition (4 ms), turbo ﬁeld echo factor (8), number
of signal averages (1), sensitivity encoding (yes), echo
train length (6), slice thickness (4 mm), spacing be-
tween slices (5 mm), ﬁeld of view (200 ! 181); ﬂip
angle (45") and matrix (200 ! 190). The parameters
for quantitative phase contrast angiography were set
at time to echo (2.9 ms), time to repetition (4.7 ms);
turbo ﬁeld echo factor (2), number of signal averages
(2), sensitivity encoding (yes), echo train length (2),
slice thickness (8 mm), spacing between slices (5
mm), ﬁeld of view (180 ! 180), ﬂip angle (10"),
matrix (120 ! 120). Measurements were acquired in
a supravalvular position over the aortic valve
perpendicular to ﬂow direction.
Every quantitative phase contrast angiography
followed a perfusion scan for which Gadolinium
(Omniscan 78.67 mg Gd mLe1; GE Healthcare AG,
Switzerland) 0.05 mmoL kge1 IV was administered
through the venous catheter.
Quantitative phase contrast angiography and
perfusion scans required apnoea. To guarantee
apnoea for the scans, ventilation was increased for 2
minutes (either increase in VT or fR) to reach PE0CO2
of 35e38 mmHg (4.7e5.1 kPa) before switching off
the ventilator. Apnoea duration was 10e25 seconds.
Figure 1 Study timeline showing magnetic resonance imaging Q-Flow stroke volume measurements (SVMRT) at baseline (B)
during different adenosine constant rate infusions (CRI) (A140: 140 mg kge1 minutee1; A280: 280 mg kge1 minutee1) and 3
and 10 minutes after discontinuing adenosine treatment.
Two adenosine constant rate infusions in anaesthetized dogs FB Joerger et al.
© 2019 Published by Elsevier Ltd on behalf of Association of Veterinary Anaesthetists and American College of Veterinary
Anesthesia and Analgesia., 46, 289e298
291
  9 
 
Arterial blood gases, electrolytes, haemoglobin,
glucose and lactate
First, 3 mL of blood was removed from the arte-
rial catheter and discarded before 1 mL of blood
was collected anaerobically into a heparinized
syringe (BD Preset; Becton, Dickinson and Com-
pany, Belgium) and analysed immediately (Rap-
idPoint 500; Siemens Healthcare Diagnostics Inc.,
NY, USA). The catheter was ﬂushed with hepa-
rinized saline. Arterial partial pressure of carbon
dioxide (PaCO2), arterial partial pressure of oxy-
gen (PaO2), pH, total haemoglobin (tHB), fraction
of oxyhaemoglobin (FO2Hb), sodium (Na
þ), po-
tassium (Kþ), ionized calcium (Ca2þ), chloride
(Cl"), glucose and lactate were measured.
Retrospective data analysis
MRI image processing and analysis
The DICOM-images were exported to a dedicated
workstation (Extended MR Workspace; Philips AG).
The same radiologist quantiﬁed ﬂow information
with an imaging software (QFlow Analysis; Philips
AG) in a post-processing step by drawing a region of
interest around the aorta. The software propagated
the region of interest to each phase of the cardiac
cycle. The automatically generated region of interests
were reviewed and manually corrected. The software
calculated ﬂow parameters based on the signal in-
tensity of the voxel representing ﬂow velocity and the
square area of the region of interest. The analysis
included the following parameters: stroke volume,
forward ﬂow, backward ﬂow, regurgitant fraction,
absolute stroke volume (SVMRT), mean ﬂux, stroke
distance and mean velocity. The results were expor-
ted to an excel sheet.
Calculated haemodynamic variables
Cardiac index (CI), cardiac output (CO), oxygen de-
livery (DO2) and arterial oxygen content (CaO2) were
calculated using conventional formulas and the
measured SVMRT. Systemic vascular resistance (SVR)
was calculated based on Stoelting and Hillier
(Stoelting & Hillier 2012) and deﬁned as approxi-
mated SVR:
CO ¼ PR x SVMRT
CI ¼ CO/(bodyweight in kg)
Approximate SVR ¼ MAP/CO $ 80
CaO2 ¼ (1.34 $ Hb $ SaO2) þ (0.003 $ PaO2)
DO2 ¼ CO $ CaO2
where Hb, haemoglobin concentration (g dLe1); SaO2,
oxyhaemoglobin saturation; PaO2, partial pressure of oxy-
gen in the blood (Grimm et al. 2015).
Recovery
After ﬁnalizing data acquisition for the study
described here, dogs were transported out of the MRI
and underwent a continuous positive airway pres-
sure study (Meira et al. 2018). After data collection
for the ventilation study, dogs were allowed to
recover. Each dog was administered a single dose of
robenacoxib 2 mg kge1 IV (Onsior; Novartis,
Switzerland).
Data handling and statistical analysis
The present study was a subproject of an imaging
trial of the canine femoral and sciatic nerves (license
number: 26164-ZH001/15) (Sievert et al. 2017),
which predetermined the total number of dogs.
Therefore, no prospective power analysis was
performed.
Statistical analyses were performed with Graph-
Pad Prism (GraphPad Software, Inc., CA, USA).
Normal distribution of all variables was conﬁrmed
using the ShapiroeWilk normality test. Conse-
quently, one-way repeated measures analysis of
variance was performed followed by Sidak’s multiple
comparisons test for multiple pairwise comparisons.
All time points were compared with baseline, and
values collected at A140 were compared with those
at A280. Results are reported as mean ± standard
deviation (SD), and signiﬁcance was set at p < 0.05.
Adjusted p values (padj) are presented for post hoc
tests.
Values of MAP 1 minute before (A140-1min,
A280-1min) and at A140 and A280, respectively,
were compared to verify stabilization of the effects of
adenosine. A Wilcoxon test was used for that purpose
(p < 0.05).
A power calculation was retrospectively performed
(SigmaPlot Version 14; Systat Software Inc., Ger-
many) for parameters showing a tendency to reach
signiﬁcance (SVMRT).
Two adenosine constant rate infusions in anaesthetized dogs FB Joerger et al.
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Results
The dogs weighed 14.11 ± 2.5 kg (mean ± SD) and
were aged 4.5±0.5 years old; half of them were male
and the other half were female, all of them entire. One
dog was excluded from analysis due to a mild mitral
insufﬁciency detected by MRI during the study.
Aortic Q-Flow data was excluded in one dog because
of technical problems to measure quantitative phase
contrast angiography at high velocity ﬂows; there-
fore, aortic Q-Flow data were analysed in eight dogs
only. Due to technical problems related to the ana-
lyser, complete blood gas analysis was only obtained
for seven dogs.
The initial dose of butorphanol (0.2 mg kge1 IV)
was repeated in two dogs. This was decided based
on clinical experience of the anaesthetist and
butorphanol was administered at least 30 minutes
before baseline measurements. Baseline measure-
ments were taken 168.7 ± 22.3 minutes after in-
duction of anaesthesia. All dogs recovered
uneventfully.
No changes in MAP were detected from A140-
1min and A280-1min to A140 and A280,
respectively. This led to the assumption that stable
adenosine effects were achieved before starting A140
and A280 measurements.
Cardiovascular data, CaO2 and DO2 are presented
in Figs 2e4. Changes over time were detected for SAP
(p ¼ 0.008), MAP (p ¼ 0.003) and DAP (p ¼ 0.004).
MAP and DAP decreased with A140 (MAP p adj ¼
0.007; DAP p adj ¼ 0.005) and A280 (MAP p adj ¼
0.002; DAP p adj ¼ 0.003) compared with baseline.
The decrease in SAP was only signiﬁcant at A280
(SAP p adj ¼ 0.03). No differences in SAP were seen
between baseline and 3 minutes (SAP p adj ¼ 0.16,
MAP p adj ¼ 0.93, DAP p adj ¼ 0.99) and 10 minutes
(SAP p adj ¼ 0.14, MAP p adj ¼ 0.60, DAP p adj ¼
0.81) after discontinuing adenosine. Also no differ-
ences were detected between the two dosages, A140
and A280, (SAP p adj ¼ 0.39; MAP p adj ¼ 0.21; DAP
p adj ¼ 0.29; Fig. 2).
No changes in PR were detected over time or be-
tween time points (p ¼ 0.134). A wide range of PR
was observed (baseline: 71e120 beats minutee1;
A140: 106e138 beats minutee1; A280: 109e150
beats minutee1).
Figure 2 Blood pressures and approximated systemic vascular resistance (SVR) of nine sevoﬂurane-anaesthetized Beagle
dogs at baseline (B), during adenosine infusion (A140: 140 mg kge1 minutee1; A280: 280 mg kge1 minutee1) and 3 and 10
minutes after discontinuing adenosine (X-axis). Points indicate mean, whiskers indicate standard deviation. *Signiﬁcantly
different to B. DAP, diastolic blood pressure; MAP, mean arterial blood pressure; SAP, systolic blood pressure.
Two adenosine constant rate infusions in anaesthetized dogs FB Joerger et al.
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The SVMRT (p ¼ 0.054) was not different
compared with baseline during both A140 and
A280 infusions. In addition, no differences were
detected between A140 and A280 (SVMRT p adj >
0.99). A retrospective power calculation showed a
power of 63% to detect a difference in SVMRT. A
change in CO was detected over time (p ¼ 0.043)
but not between individual time points. CI (p ¼
0.062) was not different during both A140 and
A280 infusions compared with baseline. Changes
over time were detected for the approximate SVR
(p ¼ 0.008). Approximate SVR was lower with
A140 (p adj ¼ 0.029) and A280 (p adj ¼ 0.015)
compared with baseline. However, no differences
were detected between the higher and the lower
adenosine doses (p adj ¼ 0.26). Approximated SVR
returned to baseline values 3 minutes after dis-
continuing adenosine (Fig. 3).
Figure 3 Pulse rate (PR), stroke volume (measured by magnetic resonance imaging; SVMRT), cardiac output (CO) and
cardiac index (CI) of nine sevoﬂurane-anaesthetized Beagle dogs at baseline (B), during adenosine infusion (A 140: 140 mg
kge1 minutee1; A 280: 280 mg kge1 minutee1) and 3 and 10 minutes after discontinuing adenosine (X-axis). Points indicate
mean, whiskers indicate standard deviation. *Signiﬁcant changes over time.
Figure 4 Oxygen content (CaO2) and oxygen delivery (DO2) of nine sevoﬂurane-anaesthetized Beagle dogs at baseline (B)
during adenosine infusion (A 140: 140 mg kge1 minutee1; A 280: 280 mg kge1 minutee1) and 3 and 10 minutes after
discontinuing adenosine (X-axis). Points indicate mean, whiskers indicate standard deviation.
Two adenosine constant rate infusions in anaesthetized dogs FB Joerger et al.
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CaO2 (p ¼ 0.278) and DO2 (p ¼ 0.136) did not
change over time (Fig. 4).
Blood gases, electrolytes, lactate and glucose
results are presented in Table 1. Statistically sig-
niﬁcant but probably clinically irrelevant changes
over time were detected for individual parameters
(pH, PaCO2, FE0Sevo, Kþ). Lactate was never
signiﬁcantly different from baseline, although it
was signiﬁcantly higher with A280 than with
A140 (p adj ¼ 0.03).
Discussion
Adenosine at the doses used, produced a decrease in
arterial blood pressure due to vasodilatation rather
than a decrease in CO. No differences between the
two doses could be detected. All values returned to
baseline within 3 minutes after discontinuing aden-
osine infusion.
A dose of 140 mg kge1 minutee1 adenosine is
routinely used in human medicine to produce
maximal vasodilatation for cMRT diagnostics (Wilson
et al. 1990; Cerqueira et al. 1994), while lower doses
have been shown to reduce requirements of iso-
ﬂurane and improve postoperative analgesia
(Segerdahl et al. 1995). In cats, a maximal dose of
280 mg kge1 minutee1 was suggested to achieve
maximal hyperaemic myocardial blood ﬂow response
by Jenni et al. (2009). Maximal vasodilatation is
important to quantify the coronary hyperaemic
response to ischaemia and exercise (Layland et al.
2014). Until now, no recommendation exists
regarding the dose rate of adenosine for cMRT di-
agnostics in dogs. Therefore, the dose rates selected
for the present study were based on the aforemen-
tioned reports.
While no known research studies exist investi-
gating time to steady state, clinical effects can be seen
10e20 seconds after starting administration and last
for up to 20 seconds after a bolus of 100 mg kge1 in
humans (Wilbur&Marchlinski 1997). An onset time
of less than 30 seconds after a single bolus (257 ±36
mg kge1) and less than 3 minutes using a CRI (984 ±
225 mg kge1 minutee1) has been reported to reduce
blood pressure by 45% in rabbits (Fukunaga et al.
1982). Based on the rapid onset time described in
other species, an infusion period of 3 minutes was
considered sufﬁcient to achieve stable cardiovascular
effects in the present study. Stabilization of MAP was
observed clinically and could be conﬁrmed retro-
spectively using statistics.
The observed decrease in blood pressure combined
with a decrease in approximate SVR and no changes
in SVMRT and PR indicates vasodilatation. The
Table 1 Blood gases, electrolytes, glucose, lactate and end-tidal sevoﬂurane measurements of seven sevoﬂurane-
anaesthetized Beagle dogs at baseline (B) during adenosine infusion (A140: 140 mg kge1 minutee1; A280: 280 mg
kge1 minutee1) and 3 and 10 minutes after discontinuing adenosine
Variable B A140 A280 Time points p
3 minutes 10 minutes
PaCO2 (mmHg) 38 ± 3 39 ± 3 40 ± 2 40 ± 2 41 ± 3 0.036a
PaCO2 (kPa) 5.0 ± 0.3 5.2 ± 0.4 5.3 ± 0.3 5.3 ± 0.2 5.4 ± 0.4
PaO2 (mmHg) 276 ± 11 277 ± 13 281 ± 14 282 ± 16 284 ± 21 0.499
PaO2 (kPa) 36.7 ± 1.5 37.0 ± 1.7 37.5 ± 1.8 37.6 ± 2.2 37.8 ± 3.0
pH 7.37 ± 0.03 7.37 ± 0.04 7.36 ± 0.04 7.36 ± 0.03b 7.35 ± 0.04b 0.001
tHB (g dLe1) 12.06 ± 0.64 11.95 ± 0.58 11.79 ± 0.61 11.98 ± 0.59 11.91 ± 0.65 0.129
FO2Hb (%) 96.7 ± 0.3 96.6 ± 0.4 96.7 ± 0.3 96.3 ± 0.7 96.8 ± 0.5 0.135
Naþ (mmol Le1) 141.5 ± 1.2 141.8 ± 1.2 141.6 ± 1.1 141.5 ± 1.0 141.4 ± 1.0 0.428
Kþ (mmol Le1) 3.94 ± 0.17 3.91 ± 0.25 3.83 ± 0.19 3.75 ± 0.16 3.77 ± 0.15b 0.033
Ca2þ (mmol Le1) 1.32 ± 0.03 1.30 ± 0.07 1.31 ± 0.04 1.33 ± 0.04 1.33 ± 0.05 0.265
Cl# (mmol Le1) 111.1 ± 1.6 110.9 ± 1.8 111.2 ± 1.8 111.0 ± 1.6 111.2 ± 1.8 0.647
Glucose (mmol Le1) 5.61 ± 0.69 5.81 ± 0.38 5.91 ± 0.28 5.76 ± 0.38 5.81 ± 0.31 0.343
Lactate (mmol Le1) 1.82 ± 0.63 1.95 ± 0.66 2.14 ± 0.74c 1.93 ± 0.58 1.93 ± 0.59 0.034
FE0Sevo (%) 3.41 ± 0.53 3.46 ± 0.52 3.49 ± 0.51 3.54 ± 0.48b 3.54 ± 0.50b 0.001
Values are presented as mean ± SD.
Ca2þ, ionized calcium; Cl#, Chloride; FE0Sevo, end-tidal sevoﬂurane; FO2Hb, fraction of oxyhaemoglobin; Kþ, potassium; Naþ, sodium; PaCO2, arterial
partial pressure of carbon dioxide; PaO2, arterial partial pressure of oxygen; tHB, total haemoglobin.
aSigniﬁcant changes over time (p < 0.05) with no signiﬁcant differences detected in post hoc tests.
bSigniﬁcantly different to B.
cSigniﬁcant difference between A140 and A280.
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vasodilatatory effects of adenosine have been previ-
ously described in humans (Skrabanja et al. 2005)
and in dogs (Lagerkranser et al. 1984). The degree of
vasodilatation has been shown to be directly dose-
dependent (Lagerkranser et al. 1984; Owall et al.
1987). However, in the present study no differences
were detected between the two adenosine CRI doses.
In contrast, Lagerkranser et al. (1984) reported lower
MAP values than our results using higher doses of
adenosine. However, comparison between different
studies is problematic as the effect of adenosine on
blood pressure could be inﬂuenced by external stim-
ulation (e.g., surgery, noise, etc.), co-administered
drugs, and might be different in conscious versus
anaesthetized patients (Cobb et al. 1974; Edlund et al.
1990). Another reason for not detecting a difference
between the two doses might have been insufﬁcient
statistical power or a relatively small difference be-
tween doses.
An adenosine-induced increase in SV and CO was
detected in dogs (Lagerkranser et al. 1984) and
humans (Skrabanja et al. 2005). In the present
study, we only detected a tendency for SVMRT to
increase during adenosine CRI (Fig. 2) without
reaching statistical signiﬁcance. However, retro-
spective power calculation revealed only 63% of
power to detect a difference. CO changed signiﬁ-
cantly over time, but no differences between indi-
vidual time points were detected. These changes
over time for CO could be the result of a parallel,
although not signiﬁcant, increase in SVMRT and PR
during adenosine CRI. The tendency to an increased
SVMRT is probably rather related to a decrease in
afterload than to an increase in contractility.
Adenosine has been shown to be negatively dro-
motropic (Wilbur & Marchlinski 1997), but the ef-
fects on the cardiac contractility are poorly
investigated. However, some in vitro studies report a
negative inotropic effect in dog and guinea pig atriae
(Chiba & Himori 1975; Gesztelyi et al. 2013; Kiss
et al. 2013). Based on our results, the two doses of
adenosine investigated did not cause predictable
changes in chronotropy. Some dogs showed an in-
crease, while others showed no changes or even a
decrease in PR during adenosine CRI. This corre-
sponds with reports in humans and dogs which
showed variable responses in heart rate independent
of the dose, injection site anaesthesia administration
(Cobb et al. 1974; Rembert et al. 1980;
Lagerkranser et al. 1984; Owall et al. 1987;
Edlund et al. 1990; Sidi & Rush 1992; Layland
et al. 2014).
The inﬂuence of adenosine infusion on DO2 has not
been investigated earlier. In our dogs, CO and CaO2
did not change between time points and infusion
doses; therefore, DO2 remained stable throughout the
study period. Although changes in PaCO2, pH, K
þ,
lactate and FE0Sevo were statistically signiﬁcant, they
were considered as clinically irrelevant.
All changes induced by adenosine returned to
baseline within 3 minutes after discontinuing
administration. A fast return to baseline was expected
as adenosine is known to have a very short half-life
(Klabunde 1983; Moser et al. 1989; Skrabanja
et al. 2005). In humans, an adenosine half-life of
0.6e10 seconds has been described (Wilbur &
Marchlinski 1997). The result of our study points
towards a short half-life in dogs too; however, future
pharmacokinetic studies are needed to conﬁrm this
assumption.
The main limitation of the study was the low
number of animals and lack of a prospective sample
size calculation. Following the three R principles, this
study was a subproject of a planned imaging study,
which limited the number of dogs to 10. Therefore,
this study was underpowered to detect changes in
some cardiovascular variables (SVMRT) and maybe
also differences between dosages.
cMRI was used to estimate SVMRT (Dennler et al.
2017), which is not a commonly used method to
measure CO but is reportedly comparable to ther-
modilution (Hockings et al. 2003; Senay et al.
2009). Still the estimation of SVMRT with this
method may have led to high SDs. The learning ef-
fect of the investigator as well as ﬁnding the
perpendicular alignment of scan plane and ﬂow di-
rection are described to impact the variability of in-
dividual calculations (Muthurangu et al. 2012;
Sargent et al. 2015). Nonetheless, in the present
study, all data were calculated by a single, very
experienced radiologist; we assume this impact to be
negligible. The MRI-based technique was chosen for
the present study because it is noninvasive and
suitable during MRI. Furthermore, as we were
interested in changes over time (between the two
dose rates and the baseline) rather than in absolute
values, we consider the method as appropriate for
our study aim. Another limitation is that only
healthy Beagle dogs were used, which will limit
extrapolation to clinical cases.
In conclusion, adenosine, at the doses studied,
produced a very short-lasting vasodilatation
without changing CO and PR in healthy
sevoﬂurane-anaesthetized dogs. Dose-dependent
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effects could not be shown in the present study. The
use of higher dosages to achieve larger decreases in
blood pressure and also the use of adenosine in
animals with heart disease requires further
investigation.
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